-
Why choose Olink for targeted protein biomarker discovery?

Olink news (Dec 13, 2018)
Available now – a new oncology panel
Olink® ONCOLOGY III offers a combination of established and exploratory protein biomarkers focused on oncology, and is available for immediate shipment as kits, or via our Analysis Service. This panel provides a perfect complement to our existing panel, Olink® ONCOLOGY II, which together now enable oncologists to measure 184 proteins in two dedicated panels. This also extends our total library of thoroughly validated protein assays to 1164.
Publications
Bom et al 2019
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease.
Chua et al 2019
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation.
Olin et al 2018
Stereotypic immune system development in newborn children. (Landmark publication in Cell).
Tromp et al 2018
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
News & Events Highlights
Olink into Asia
We are delighted to int...
Nordic Precision Medicine Forum 2019
Olink Proteomics will once again be attending this important event for the prec...
Available now- a new protein biomarker panel for oncology
December 13, 2018. A new 92-plex protein panel containing a combination of est...
14th Annual Biomarkers Congress
Olink Proteomics is delighted to be sponsoring the 14th Annual Biomarkers Congr...
The Olink Community Meets at the Nobel Forum,
View the video and get a flavor of the major international meeting, “Precision Proteomics to Drive Personalized Medicine“, which Olink arranged at the Nobel Forum in Stockholm on June 19, 2018. This global event brought together leading scientists from both academia and industry to listen to a series of outstanding presentations and to engage in important discussions around the increasing importance of protein biomarkers for the development of more personalized healthcare.